RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arecor Therapeutics Stock

Arecor Therapeutics Equity 2024

Arecor Therapeutics Equity

9.53 M GBP

Ticker

AREC.L

ISIN

GB00BMWLM973

WKN

A3CRY2

In 2024, Arecor Therapeutics's equity was 9.53 M GBP, a -45.42% increase from the 17.45 M GBP equity in the previous year.

Arecor Therapeutics Aktienanalyse

What does Arecor Therapeutics do?

Arecor Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Arecor Therapeutics's Equity

Arecor Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Arecor Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Arecor Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Arecor Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Arecor Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Arecor Therapeutics stock

What is the equity of Arecor Therapeutics this year?

Arecor Therapeutics has equity of 9.53 M GBP this year.

What was the equity of Arecor Therapeutics compared to the previous year?

The equity of Arecor Therapeutics has increased/decreased by -45.42% decreased compared to the previous year.

What impact does a high equity have on investors of Arecor Therapeutics?

A high equity is advantageous for investors of Arecor Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Arecor Therapeutics?

A low equity can be a risk for investors of Arecor Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Arecor Therapeutics affect the company?

An increase in equity of Arecor Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Arecor Therapeutics affect the company?

A reduction in equity of Arecor Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Arecor Therapeutics?

Some factors that can affect the equity of Arecor Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Arecor Therapeutics so important for investors?

The equity of Arecor Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Arecor Therapeutics take to change the equity?

To change equity, Arecor Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Arecor Therapeutics pay?

Over the past 12 months, Arecor Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arecor Therapeutics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Arecor Therapeutics?

The current dividend yield of Arecor Therapeutics is .

When does Arecor Therapeutics pay dividends?

Arecor Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arecor Therapeutics?

Arecor Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Arecor Therapeutics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arecor Therapeutics located?

Arecor Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arecor Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arecor Therapeutics from 10/2/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Arecor Therapeutics pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Arecor Therapeutics in the year 2023?

In the year 2023, Arecor Therapeutics distributed 0 GBP as dividends.

In which currency does Arecor Therapeutics pay out the dividend?

The dividends of Arecor Therapeutics are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Arecor Therapeutics

Our stock analysis for Arecor Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arecor Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.